Background: The aim of the present study was to investigate the blood transfusion practice in patients operated for abdominal aortic aneurysm (AAA) with special emphasis on massive transfusion in cases with rupture. Material and methods: From a database, 504 patients operated for AAA were stratified into 2 groups; an early transfusion period (1992)(1993)(1994)(1995)(1996)(1997)(1998)(1999)) and a late transfusion period (2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008) to evaluate the changes in transfusion practices over the course of time. Results: Patients operated for nonruptured AAA (n ¼ 330) showed a decreased mortality rate from 4% (early transfusion period) to 1% (late transfusion period) without significant changes in the transfusion practices. In patients operated for ruptured AAA (n ¼ 174) an unexpected low mortality rate was found compared to the 30-day mortality reported in earlier studies. The transfusion practices in ruptured AAA surgery showed a significant increase in platelet use and change of fresh frozen plasma: red blood cell ratio from 0.8 to 0.9 between the early and the late transfusion period. Conclusion: The present database study shows that the operating mortality for AAA surgery has declined during the past decades. The cause of the decline in mortality in patients with ruptured AAA was interpreted as partly due to a modern blood component therapy.
Introduction
Abdominal aortic aneurysm (AAA) is a common and often asymptomatic condition until the catastrophic event of hemorrhagic shock due to aneurysm rupture. 1, 2 Despite advances in surgical and anesthetic techniques the reported perioperative mortality remains high, around 50%, in patients with ruptured AAA. 1 Earlier reports indicate that a major cause of immediate intraoperative death in patients with ruptured AAA is due to coagulopathy related to hemorrhage. 3 However, the survival after AAA repair has improved in Sweden since the millennium. 4 Furthermore, a recent study found that fatal coagulopathy was relatively uncommon; instead there was a high incidence of thrombosis-related deaths in patients with AAA with shock due to rupture. 5 The transfusion practices have changed in the last 3 decades with the introduction of bloodcomponent treatment to patients with hemorrhagic shock. 6, 7 During the past 30 years the transfusion policy has changed from a combination of red blood cell (RBC), crystalloid, and/ or colloids to the use of plasma and platelets instead of crystalloids and colloids. Modern management of the patient with hemorrhage due to ruptured AAA includes rapid administration of large amounts of RBC units, along with sufficient fresh frozen plasma (FFP) and platelets to treat or prevent coagulopathy. For the last 10 years the optimal FFP:RBC ratio in massive bleeding has been a hot topic in the medical literature. 6, 7 Most of the studies concerning survival after massive blood transfusion are based on patients with trauma and little has been investigated concerning blood transfusion practices in AAA surgery. Hence, based on the above discussion we have examined the blood transfusion practice in patients operated on for AAA between 1992 and 2008 to investigate a change in blood transfusion practice as the possible explanation for the improved survival.
Materials and Methods

All vascular surgical procedures (both open and endovascular)
for AAA at Sundsvall County Hospital are prospectively registered in the national registry Swedvasc (The Swedish Vascular Registry). 8, 9 To evaluate the changes in transfusion practices over the course of time the patients were stratified into an early transfusion period (1992-1999) and a late transfusion period (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) . Total number of transfused units of RBC, FFP, and platelets during the hospital stay were extracted from the hospital blood bank database. The 30-day mortality and complications were obtained from the Swedvasc registry. The study protocol was in accordance with the Declaration of Helsinki and subsequent amendments.
Patients with ruptured AAA are expected to require a massive transfusion (>10 units of RBC in 24 hours) and is per se defined as a massive transfusion situation. The routine in our hospital during the study period was to order 4 to 10 units of RBC and equal numbers of FFP immediately at diagnosis. Platelets were ordered later on demand. No blood transfusions were given before laparotomy and, in accordance with Crawford, no significant attempt was made at blood volume resuscitation until surgery. 10 In obscure cases ultrasound was performed by the surgeon in the emergency department. At diagnosis the patients were promptly transferred to the operating room for open aortic repair by a vascular surgeon. A temporary initial aortic clamping at the supraceliac level was the standard approach at our department in patients operated on for ruptured AAA. 11 In an emergency situation O RhD negative RBC was available for immediate delivery. The ABO compatible RBC and FFP were delivered as soon as possible. In the initial resuscitation phase plasma was delivered as liquid stored plasma or thawed FFP (stored at þ4 C in maximal 7 days). 12, 13 No cryoprecipitate was used; however, factor concentrates were used in selected cases for example acute patients on Warfarin.
In patients with nonruptured AAA platelet count, activated partial thromboplastin time, and prothrombin time were used as preoperative screening for bleeding risk. 14 Hemoglobin trigger levels were between 80 and 100 g/L due to the cardiopulmonary condition in each individual case. 15 Cell saver was not used because it was not regarded as cost-effective in elective cases. 16 Even in patients with massive hemorrhage due to ruptured AAA cell saver was avoided due to the risk of the emergence of a hyperfibrinolytic state. 17, 18 
Statistical Analysis
All analyses were carried out using SPSS statistical software 16.0 for Windows (SPSS, Chicago, Illinois). Median (interquartile range) values were calculated for continuous variables and categorical data were expressed as absolute numbers with percentages. Differences in findings between study groups were assessed by Fisher exact test (2-tailed) for categorical variables and by Mann-Whitney U tests for continuous variables. Results were considered statistically significant when P values were <.05.
Results
Between January 1992 and December 2008, 504 patients (430 men and 74 women) underwent vascular surgical procedures (both open and endovascular) for AAA in our department. Cases of mycotic aneurysm and second operations were not included. A total of 174 patients with ruptured infrarenal AAA were included. All patients had a confirmed retroperitoneal hematoma and 132 had signs of clinical shock with at least 1 episode of hypotension (systolic pressure of <80 mm Hg) prior to aortic cross clamping. 9 The remaining 42 patients were not in clinical shock. Also, 330 patients with an acute or elective operation for nonruptured infrarenal AAA were included. All patients underwent conventional open AAA repair through a standard midline laparotomy incision and transperitoneal approach with infrarenal graft repair with the exception of 40 cases with nonruptured AAA treated by endovascular aortic repair (EVAR) during 2006 to 2008. The 30-day mortality in all patients with ruptured AAA (n ¼ 174) during 1993 to 2008 was 25%; however, an insignificant decrease in mortality between the early (31%) and the late (20%) transfusion periods were noted ( Table 1 ). The use of platelets was significantly higher in the late transfusion period compared to the early transfusion period ( Table 1 ). The FFP: RBC ratio increased significantly (P ¼ .001) from 0.8 in the early period (n ¼ 62 cases with both RBC and FFP transfusion) to 0.9 in the late period (n ¼ 92 cases with both RBC and FFP transfusion). As shown in Table 1 there was no proven change in transfusion practices between the early and the late transfusion period in patients operated on for nonruptured AAA. In both transfusion periods, approximately one-third of the patients operated on for nonruptured AAA were not transfused. The mortality rates for nonruptured AAA surgery decrease, however not significantly, from 4% (early transfusion period) to 1% (late transfusion period). 
Discussion
In this database analysis, the 30-day mortality in patients operated on for nonruptured AAA was comparable to other reports. 1 Instead, strikingly low mortality in patients operated on for ruptured AAA was observed compared to the previously reported mortality. 1, 2, 19 However, the low 30-day mortality (25%) in patients with ruptured AAA in the present study was consistent with the improvement in survival shown in a recent report from Sweden. 6 The improvement in survival probably has many causes. Early diagnosis in obscure cases is crucial in preventing fatal delay to surgery: increased attention to typical signs and symptoms, emergency access to abdominal ultrasound, and computer tomographic investigation all facilitate AAA rupture diagnosis. Advances in anesthetic techniques including aggressive rewarming to prevent hypothermia by warm fluid infusion, forced air warming, and the use of warm water on the surgical field to prevent coagulopathy are other possible explanations for the improved survival rate. Furthermore, modern management of patients with hemorrhage due to ruptured AAA with rapid administration of large amounts of RBC, along with sufficient plasma and platelets probably improves the survival rate. In the present study we have evaluated changes in transfusion practices between an early transfusion period (1992-1999) and a late transfusion period (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) . There were no significant changes in transfusion practices between the 2 periods for nonruptured AAA surgery. The transfusion practices in ruptured AAA surgery showed a significant increase in platelet use and change of FFP: RBC ratio from 0.8 to 0.9 between the early and the late transfusion period. The use of more plasma and platelets in ruptured AAA surgery was consistent with a recent recommendation given by Johansson et al. 20 However, the association between the change in transfusion practices and the decrease in mortality rate from 31% to 20% may be due to bias and/or limitations. There are several limitations to the present study. First, the unknown real death of ruptured AAA patients due to a low autopsy rate in the study population casts some doubt on the operative mortality rate. Second, the present study lacks data about the time course of the transfusion and the amount of administrated crystalloids and colloids which is perhaps more important than the total amount of blood component units given. Finally, absence of data about symptom duration is a limitation as the delay to surgery influences the survival.
In conclusion, the operating mortality for AAA surgery has declined. The prominent decline in mortality in patients with ruptured AAA is likely due, in part, to modern blood component therapy. However, the highest priority in hemorrhagic shock directly related to survival is to stop the bleeding. Hence, we believe that the most important cause of the low mortality in our department is the fact that all emergency cases were operated by a vascular surgeon familiar with elective aneurysm surgery, damage control approach, and temporary supraceliac aortic clamping in cases with ruptured AAA. Further improvement is to be expected with the introduction of EVAR even in cases of ruptured AAA with use of a transfemoral aortic balloon catheter to stop the bleeding. 21, 22 Finally, goal-directed transfusion therapy guided by thromboelastograhpy is likely the optimal solution instead of transfusion with fixed FFP/RBC ratio. 6, 23 
